Introduction
Local anesthetics have been found to induce brain neural injury in human patients. 1 Local anesthetics can induce permanent injury in young patients, and even affect neurobehavioral outcomes.
2 Bupivacaine (Bup) is a common local anestheticused for postoperative pain relief. 3 A recent study indicated that 5% Bup can induce histopathological abnormalities in a rat model. 4 Meanwhile, injection of Bup can also lead to serious sciatic nerve damage in rats. 5 Even with a normal or lower dose, Bup can induce neurotoxicity in cells. 6 As such, it is urgent that we develop novel effective methods for the treatment oflocal anestheticneurotoxicity.. Andrographolide (Andro) is a natural diterpenoid extracted from the tradition Chinese herbal medicine Andrographis paniculate. 7 Andro has been revealed to exhibit a variety of biological activities, including antitumor, anti-inflammatory, antivirus, and antioxidation actions. [8] [9] [10] [11] [12] A previous study indicated that Andro can stimulate neurogenesis in the adult hippocampus. 13 Liang et al found that Andro may exhibit neuroprotective effects in nervous system diseases. 14 Meanwhile, a recent study showed that Andro exerted strong neuroprotective effects in a mouse model of Parkinson's disease. 15 However, it remains unclear whether Andro provides neuroprotection against Bup. In addition, the Aktsignaling pathway participates in regulating cell growth, survival, and death. 16 Studies have indicated Bup-induced apoptosis in neural injury via inactivation of the Akt pathway. 17, 18 Therefore, our main purpose was to investigate the effect of Andro on Bup-induced neurotoxicity in SH-SY5Y cells. In this study, an in vitro model of Bup-induced cytotoxicity was first established. Then, mechanisms by which Andro regulates Bup-induced injury in SH-SY5Y cells were evaluated.
Methods

Cell cultures
The human neuroblastoma cell line SH-SY5Y was purchased from the American Type Culture Collection (Rockville, MD, USA). SH-SY5Y cells were cultured in DMEM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS(Thermo Fisher Scientific) and 100 U/mL penicillin-streptomycin at 37°C in a humidified 5% CO 2 incubator. Cell-culture medium was changed daily. Andro (365645) and Bup (B5274) were obtained from Sigma-Aldrich (St Louis, MO, USA). AZD5363 was purchased from MedChem Express (Monmouth Junction, NJ, USA).
CCK8 assay
A CCK8 assay kit (Beyotime, Haimen, China) was used to determine cell viability. SH-SY5Y cells were seeded into a 96-well plate at a density of 5×10 3 Figure 5A ), SH-SY5Y cells were incubated with Andro (0 or 200 μM) for 12 hours. Then, the culture medium was changed and cells incubated with 10 nM AZD5363 for 1 hour. Later, the culture medium was changed and cells incubated with Bup (0 or 400 μM) for another 48 hours. Next, cells were incubated with primary antibodies for anti-p-Akt (1:1,000;Abcam) and DAPI (1:1,000) at 4°C overnight. After that, cells were incubated with goat antirabbit IgG secondary antibodies (1:5,000;Abcam) at 37°C for 1 hour. Cells were visualized with fluorescence microscopy (Olympus, Tokyo, Japan). 
Flow-cytometry analysis of cell apoptosis
Western blot analysis
Total cellular protein was quantified with a BCA protein assay kit (Beyotime). An equal amount of protein samples (40 μg/lane) was separated by polyacrylamide-gel electrophoresis. Then, proteins were transferred to polyvinylidene fluoride membranes (Thermo Fisher Scientific). After blocking with 5% nonfat milk for 50 minutes, membranes were incubated with primary antibodies overnight at 4°C. After that, membranes were incubated with secondary antibody for 1 hour at room temperature. Primary antibodies usedwereanti-Bax (1:1,000), anti-Bcl2 (1:1,000), anti-active caspase 3 (1:1,000), anti-p-Akt (1:1,000), anti-p-mTOR (1:1,000), and anti-β-actin (1:1000). The secondary antibody was goat antirabbit IgG (1:5,000). All these antibodies were provided by Abcam. Finally, images protein bands were captured with an electrochemiluminescence reagent (Santa Cruz Biotechnology). The density of blots for targets was normalized to β-actin.
Glutathione assay
ELISA kits (Beyotime) were used to detect levels of intracellular reduced glutathione (GSH) and oxidized GSH (GSSG). Absorbance was read at 450 nm by a microplate reader (Thermo Fisher Scientific). The level of total GSH was the sum of GSH and GSSG.
Intracellular ROS assay
A reactive oxygen species (ROS) assay kit (Beyotime) was used to detect the level of intracellular ROS. Intracellular ROS level was alsodetected with a microplate reader (Thermo Fisher Scientific).
Statistical analysis
Each group was subjected to least three independent experiments, and all data are expressed as means ± SD. Student's t-test was used to analyze comparison betweens two groups.
Comparisons among multiple groups were made with oneway ANOVA followed by Dunnett's test. P<0.05 was considered statistically significant.
Results
Effects of Bup or andro on growth of SH-SY5Y cells
The chemical structure of Andro is indicated in Figure 1A . CCK8 assays were used to investigate the effects of Bup or Andro on the growth of SH-SY5Y cells. As shown in Figure 1B , Bup significantly inhibited the viability of SH-SY5Y cells in a dose-dependent manner. Since 400 μM Bup induced about 50% growth inhibition, 400 μM Bup was utilized in the following experiments. Meanwhile, Andro had a very limited effect on cell proliferation when the concentration reached 200 μM ( Figure 1C ).
However, 400 μM Andro had significant cytotoxicity. Therefore, 200 μM Andro was utilized in the following experiments.
Andro alleviated Bup-induced cytotoxicity in SH-SY5Y cells via inhibition of apoptosis
As indicated in Figure 2A , the cytotoxicity of 400 μM Bup on SH-SY5Y cells was significantly alleviated by Andro (100 or 200 μM) treatment. Next, a Ki67 immunofluorescence assay was used to determine cell viability as well.
The results showed Bup markedly inhibited cell proliferation, which was notably reversed by 200 μM Andro ( Figure 2 , B and C). In addition, flow cytometry was applied to explorefurtherthe apoptosis in SH-SY5Y cells. The rate of early and late apoptotic stage in Bup-treated SH-SY5Y cells was about 10% and 20.00%, respectively. However, the rate of early-and late-apoptosis stages in Bup-treated SH-SY5Y cells was markedly decreased to about 4% and 10% in the presence of Andro ( Figure 2 , D and E), respectively. These results indicated that Andro significantly decreased Bup-induced apoptosis in SH-SY 5Y cells. As such, Andro inhibited Bup-induced cytotoxicity via inhibition of apoptosis in SH-SY5Y cells.
Andro attenuated Bup-induced cytotoxicity in SH-SY5Y cells via increasing antioxidative status
Oxidative status is an important cell characteristic included in the response to cellular environment transformation. Generation of ROS and GSH mediates apoptosis in neuroblastoma SH-SY5Y cells. 19, 20 As shown in Figure 3 , A and B, Bup 
Andro inhibited Bup-induced cytotoxicity in SH-SY5Y cells via activating p-Akt and p-mTOR
To explore further the effects of Andro on Bup-induced apoptosis in SH-SY5Y cells, Western blotting was performed. It has been reported that Bcl2 and caspase 3 are proapoptotic proteins, while Bax is an antiapoptotic protein. 21 In addition, the Akt-mTOR pathway plays an important role in cell survival and death. 22 As indicated in Figure 4 , Bup significantly increased Bax and active caspase 3 expression and decreased levels of Bcl2, p-Akt, and p-mTOR in cells compared with the control group. However, these effects were markedly reversed in the presence of Andro (Figure 4) . Therefore, these data suggested that Andro attenuated Bup-induced cytotoxicity in SH-SY5Y cells via activating the Akt-mTOR pathway.
Akt inhibitor abrogated the protective effect of Andro in Bup-treated SH-SY5Y cells
To investigatefurtherwhether Andro attenuated Bupinduced cytotoxicity via the Akt pathway, the Aktselective inhibitor AZD5363 was used. As indicated in CCK8 assays, the protective effect of Andro in SH-SY 5Y cells against Bup was abrogated by AZD5363 treatment; however, AZD5363 notably increased Bup-induced cytotoxicity ( Figure 5A ). Meanwhile, the antiapoptotic effect of Andro in Bup-treated SH-SY5Y cells was also reversed by AZD5363 treatment ( Figure 5 , B and C). These data suggested that the Akt inhibitor abrogated the protective effect of Andro in Bup-treated SH-SY5Y cells. In addition, AZD5363 abolished the upregulation of p-Akt and p-mTOR in cells, even in the presence of Andro ( Figure 6, A-C) . Meanwhile, the expression of active caspase 3 in cells was significantly increased with treatment by AZD5363. Similarly, immunofluorescence assays indicated the expression of p-Akt in SH-SY5Y cells was significantly inhibited by AZD5363, even in the presence of Andro (Figure 6 , D and E). All these data confirmed that Andro inhibited Bup-induced cytotoxicity of SH-SY5Y via preserving the Akt-mTOR pathway, which was abrogated by AZD5363. 
Discussion
In the present study, we found that Andro protected SH-SY 5Y cells from Bup-induced cytotoxicity. Pretreatment with 200 μM Andro significantly suppressed Bup-induced cytotoxicity, apoptosis, and ROS accumulation. A study has shown that Bup induced neurotoxicity in neuroblastoma Neuro2a cells via activating apoptosis. 23 Wen et al showed that Bup induced neural injury in SH-SY5Y cells, 24 consistent with the results of this study. In addition, we found that 200 μM Andro had no cytotoxicity on SH-SY5Y cell proliferation. Consistently with previous research, ginkgolide B had no effect on cell proliferation, while pretreatment with ginkgolide B protected SH-SY5Y cells from Bupinduced neurotoxicity. 25 Furthermore, Chen et al indicated that paeoniflorin attenuated Bup-induced neurotoxicity via downregulation of Bax and caspase 3 levels n SH-SY5Y cells. 21 Harato et al also showed that Bup induced apoptosis in mouse neuro2a cells via increasing the expression of caspase 3 and inducing ROS generation. 26 In this study, An important element of cellular survival is oxidoreductive homeostasis. In neuronal cells, the course of cell apoptosis is associated with ROS and GSH generation. 27, 28 Park et al found that Bup-induced apoptosis was associated with the production of ROS. 29 Lu et al showed Bupinduced apoptosis in SH-SY5Y cells via induction of ROS production and activation of the AMPK pathway. 30 However, inhibition of GSH can induce apoptosis. Our findings are consistent with previous reports that Bup increased ROS generation and decreased total GSH level in SH-SY5Y cells. Moreover, Andro is considered an antioxidant, 31 and we demonstrated the effects of Andro on ROS and total GSH content in Bup-treated SH-SY5Y cells. We found that ROS content was reduced and the level of total GSH increased with Andro treatment. Supporting our finding, Andro-attenuated hypoxia-induce s the production of ROS. 32 As such, Andro recover ROS and GSH to normal levels in Bup-treated SH-5Y5Y cells and played an important role in maintaining oxidoreductive homeostasis. Akt, a serine/threonine-specific protein kinase, can modulate cell death and survival in multiple cellular processes. 33 The primary direct downstream effector protein of Akt is mTOR. 33 mTOR is a main nodal point of regulation for ribosome biogenesis and protein translation. 33 The Akt-signaling pathway has been found to be involved in Bup-induced neural injury. 34 In this study, we observed that Bup markedly decreased the expression of p-Akt and p-mTOR. This is consistent with Zhao et al's report that Bup induced neurotoxicity in SH-SY5Y cells via inhibiting the PI3K-Akt pathway. 34 Importantly, we found that Andro attenuated Bup-induced cytotoxicity via preserving Akt/mTOR activity in SH-SY5Y cells. Chen et al also found that Andro inhibited endothelial cell apoptosis through activation of the PI3K-Akt signaling pathway. 35 Therefore, it is presumed that Andro rescued Bup-induced cytotoxicity via preserving Akt/mTOR activity in SH-SY 5Y cells. To verify these data, the Akt-selective inhibitor AZD5363 was used in this study. AZD5363 abrogated the protective effect of Andro in Bup-treated SH-SY5Y cells. These results suggested that Andro exerted its neuroprotective effects through preserving the Akt-mTOR signaling pathway. However, a limitation of the current study was the lack of animal experiments, which hindered the clinical use of Andro.
Conclusion
In summary, this study indicated that Andro alleviated Bup-induced cytotoxicity in SH-SY5Y cells via inhibition of apoptosis and ROS generation and activation of the Akt-mTOR signaling pathway. Therefore, Andro may be a potential agent for the treatment of human cytotoxicity induced by Bup.
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